Limited Access to C. diff Drugs Through Medicare

While drugs recommended for the treatment of CDI are commonly included on the formularies for most people who are ...

AUGUST 19, 2022

Controversy Continues on Open-Label FMT for Resistant C. diff

The FDA held another meeting to discuss the safety of making FMT available to patients before an approved product ...

NOVEMBER 5, 2019

Pharmacologic Therapy for Managing CDI

A number of pharmacologic therapies are available or in clinical development to treat Clostridioides difficile ...

OCTOBER 3, 2019

Antibiotics and PPIs Linked to Increased C. diff Risk in Children

Prior antibiotic exposure and use of proton pump inhibitors may increase the risk of C. diff among hospitalized ...

MARCH 13, 2019

New C. diff Rapid Diagnostic Test Registered With FDA

Matching the sensitivity and specificity of CNNA means that the new C. diff test has the potential to reduce the ...

OCTOBER 7, 2018

SHEA Panel Provides Recommendations for Managing CDI in NICU

Routine testing for CDI should not be done in infants younger than 12 months of age who are in the NICU, ...

SEPTEMBER 13, 2018

Enhanced Hospital Disinfection Reduces Disease Spread

Disinfecting hospital rooms using enhanced techniques reduces the spread of epidemiologically important pathogens.

SEPTEMBER 7, 2018

Antisense Antimicrobials Make Sense for CDI

Researchers have developed three new antibiotics that use antisense therapy to kill Clostridium ...

JUNE 25, 2018

Chlorhexidine Bathing May Not Be More Effective Than Soap and Water to Prevent CDI

Bathing ICU patients every other day with a 2% chlorhexidine gluconate solution did not prevent hospital-acquired ...

JUNE 22, 2018

C. difficile Management Strategy Pays Off

In early 2016, the University of Wisconsin (UW) Health, in Madison, had the unenviable distinction of being in the ...

MAY 8, 2018

New C. difficile Guidelines Recommend New Treatment, Testing Protocols

CDI affects nearly 500,000 Americans every year, resulting in 15,000 to 30,000 deaths and costing more than $4.8 ...

FEBRUARY 15, 2018

Sanofi Ends Development of Clostridium difficile Vaccine

Sanofi ends Clostridium difficile vaccine trials.

DECEMBER 1, 2017